National Beverage
FIZZ Nasdaq Soft Drinks & Non-alcoholic Beverages Financials FY2017βFY2026
National Beverage's revenue fell 1.7% to $1.2 billion in fiscal 2026. Its operating margin was 19.5%, down from 19.6% a year earlier. Free cash flow was $156 million, down 8.4%. It paid out $1 million in dividends and buybacks, 0% of free cash flow.
About these figures. Share counts and per-share figures for earlier years are restated for a stock split (2-for-1), so every year is on today's share basis.
What National Beverage does
No business description yet.
- Legal name
- National Beverage Corp.
- Fiscal year ends
- May 2, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001437749-26-022315
0000069891
Revenue and margins
National Beverage had $1.2B of revenue in fiscal 2026, down 1.7% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 6.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $156M in fiscal 2026, 13.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
National Beverage returned $0.7M to shareholders in fiscal 2026, 0% of free cash flow. The diluted share count fell 0.0%.
Value National Beverage yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $350M and divides by 93.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 19.4x Β· peers 28.4x Β· sector 24.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably National Beverage can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $48.0M | $158M | $327M | $194M | $350M |
| Debt incl. finance leases | $30.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | β0.1x | β0.8x | β1.4x | β0.8x | β1.4x |
| Debt / equity | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 560.3x | 592.7x | 958.4x | 2,029.8x | 827.7x |
| Current ratio | 1.9x | 2.5x | 3.9x | 2.9x | 4.4x |
| Quick ratio | 1.2x | 1.9x | 3.3x | 2.3x | 3.7x |
| Total assets | $468M | $574M | $770M | $673M | $852M |
| Total liabilities | $228M | $202M | $211M | $229M | $216M |
| Shareholders' equity | $239M | $373M | $560M | $444M | $636M |
| Net debt (β = net cash) | β$18.0M | β$158M | β$327M | β$194M | β$350M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
1 insider
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Glenn J. WaldmanDirector | Bought | 250 | $31.78 | $0.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 4 / 9 | 7 / 9 |
| Accruals ratio | β3.2% | β2.8% | 0.3% |
| Altman Z'' | 10.36 | 9.01 | 10.74 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| National Beverage FIZZ | $3.4B | β1.7% | 19.5% | 13.2% | 65.5% | 19.4x | 7 | |
| Vita Coco COCO | $3.4B | 18.2% | 13.5% | 6.4% | 55.3% | 28.4x | 5 | Compare β |
| Celsius CELH | $7.3B | 85.5% | 5.6% | 12.9% | 25.1% | 123.8x | 5 | Compare β |
| Coca-Cola Consolidated COKE | β | 4.8% | 13.2% | 8.6% | 39.7% | β | β | Compare β |
| Monster Beverage MNST | $45.7B | 10.7% | 29.2% | 23.7% | 36.1% | 21.4x | 9 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $827M | $976M | $1.0B | $1.0B | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $1.2B |
| Gross profit | $326M | $391M | $384M | $370M | $422M | $418M | $397M | $429M | $444M | $437M |
| Operating income | β | $204M | $180M | $166M | $228M | $208M | $187M | $219M | $236M | $230M |
| Interest expense | $0.2M | $0.2M | $0.2M | $0.1M | $0.1M | $0.4M | $0.3M | $0.2M | $0.1M | $0.3M |
| Pretax income | $163M | $206M | $184M | $170M | $228M | $208M | $186M | $230M | $245M | $241M |
| Income tax | $55.8M | $55.7M | $43.0M | $39.5M | $54.0M | $49.1M | $44.3M | $53.1M | $57.7M | $56.9M |
| Net income | $107M | $150M | $141M | $130M | $174M | $159M | $142M | $177M | $187M | $184M |
| Diluted EPS | $1.15 | $1.59 | $1.50 | $1.39 | $1.86 | $1.69 | $1.52 | $1.89 | $1.99 | $1.96 |
| Diluted shares | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B |
| Cash flow | ||||||||||
| Cash from operations | $114M | $155M | $139M | $178M | $194M | $133M | $162M | $198M | $207M | $181M |
| Capital expenditure | $14.0M | $32.0M | $38.3M | $23.9M | $25.3M | $29.0M | $22.0M | $30.3M | $36.3M | $25.1M |
| Free cash flow | $100M | $123M | $101M | $154M | $168M | $104M | $140M | $168M | $170M | $156M |
| Depreciation and amortization | $12.8M | $13.2M | $15.4M | $17.2M | $18.1M | $18.5M | $20.0M | $20.2M | $20.8M | $22.7M |
| Stock-based compensation | $0.2M | $0.2M | $0.3M | $0.1M | $0.5M | $0.7M | $0.7M | $0.9M | $0.6M | $0.4M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $6.2M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.7M |
| Dividends paid | $69.8M | $69.9M | $135M | $0.0M | $280M | $280M | $0.0M | $0.0M | $304M | $0.0M |
| Dividends and buybacks | $69.9M | $69.9M | $135M | $6.2M | $280M | $280M | $0.0M | $0.0M | $304M | $0.7M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $136M | $190M | $156M | $305M | $194M | $48.0M | $158M | $327M | $194M | $350M |
| Total debt | β | β | β | β | $0.0M | $30.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $268M | $353M | $322M | $461M | $365M | $275M | $366M | $537M | $407M | $593M |
| Current liabilities | $87.2M | $105M | $97.0M | $142M | $147M | $145M | $144M | $138M | $141M | $135M |
| Inventory | $53.4M | $60.9M | $70.7M | $63.5M | $71.5M | $103M | $93.6M | $84.6M | $85.1M | $95.5M |
| Property and equipment, net | $65.1M | $85.8M | $111M | $121M | $131M | $144M | $148M | $160M | $176M | $182M |
| Total assets | $354M | $459M | $452M | $649M | $557M | $468M | $574M | $770M | $673M | $852M |
| Total liabilities | $108M | $127M | $121M | $196M | $201M | $228M | $202M | $211M | $229M | $216M |
| Shareholders' equity | $246M | $331M | $332M | $452M | $356M | $239M | $373M | $560M | $444M | $636M |
| Margins | ||||||||||
| Gross margin | 39.4% | 40.1% | 37.9% | 37.0% | 39.3% | 36.7% | 33.8% | 36.0% | 37.0% | 37.0% |
| Operating margin | β | 20.9% | 17.7% | 16.6% | 21.3% | 18.3% | 15.9% | 18.3% | 19.6% | 19.5% |
| EBITDA margin | 21.3% | 22.3% | 19.3% | 18.3% | 22.9% | 19.9% | 17.6% | 20.0% | 21.3% | 21.4% |
| Net margin | 13.0% | 15.4% | 13.9% | 13.0% | 16.2% | 13.9% | 12.1% | 14.8% | 15.6% | 15.6% |
| FCF margin | 12.1% | 12.6% | 10.0% | 15.4% | 15.7% | 9.2% | 11.9% | 14.1% | 14.2% | 13.2% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | 82.7% | 65.3% | 75.2% | 74.5% | 65.5% |
| Return on capital employed | 65.6% | 65.8% | 50.7% | 38.5% | 49.7% | 56.8% | 49.6% | 41.1% | 40.4% | 36.9% |
| Return on equity | 47.4% | 51.9% | 42.5% | 33.2% | 43.1% | 53.2% | 46.5% | 37.9% | 37.2% | 34.0% |
| Return on assets | 32.5% | 36.9% | 30.9% | 23.6% | 28.9% | 30.9% | 27.3% | 26.3% | 25.9% | 24.1% |
| Growth | ||||||||||
| Revenue growth | 17.3% | 18.0% | 3.9% | β1.4% | 7.2% | 6.1% | 3.1% | 1.6% | 0.8% | β1.7% |
| Net income growth | 74.9% | 39.9% | β6.0% | β7.7% | 34.0% | β9.0% | β10.3% | 24.3% | 5.7% | β1.7% |
| EPS growth | 74.8% | 39.3% | β6.0% | β7.3% | 33.8% | β9.1% | β10.1% | 24.3% | 5.3% | β1.5% |
| FCF growth | 46.7% | 22.4% | β17.6% | 52.1% | 9.5% | β38.2% | 34.2% | 20.0% | 1.7% | β8.4% |
| Share count change | 0.2% | 0.3% | β0.0% | β0.2% | β0.0% | β0.0% | 0.0% | 0.0% | 0.1% | β0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β0.8x | β0.1x | β0.8x | β1.4x | β0.8x | β1.4x |
| Debt / equity | β | β | β | β | 0.0x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 862.5x | 1,015.9x | 890.8x | 3,249.9x | 1,539.4x | 560.3x | 592.7x | 958.4x | 2,029.8x | 827.7x |
| Current ratio | 3.1x | 3.4x | 3.3x | 3.3x | 2.5x | 1.9x | 2.5x | 3.9x | 2.9x | 4.4x |
| Quick ratio | 2.5x | 2.8x | 2.6x | 2.8x | 2.0x | 1.2x | 1.9x | 3.3x | 2.3x | 3.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 3.3% | 3.8% | 2.4% | 2.4% | 2.6% | 1.9% | 2.5% | 3.0% | 2.1% |
| Stock comp / revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% |
| Payouts / FCF | 69.7% | 56.9% | 133.8% | 4.1% | 166.1% | 268.9% | 0.0% | 0.0% | 178.5% | 0.4% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | 5.0 | 7.0 | 6.0 | 4.0 | 7.0 |
| Altman Z'' | 10.9 | 11.5 | 6.6 | 9.6 | 9.1 | 7.4 | 8.7 | 10.4 | 9.0 | 10.7 |
| Accruals ratio | β2.2% | β1.2% | 0.3% | β8.7% | β3.3% | 5.0% | β3.7% | β3.2% | β2.8% | 0.3% |
Source: SEC EDGAR XBRL filings (CIK 0000069891). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.